Some patients needing kidney transplants have to wait much longer than others because of their sensitization to human leukocyte antigen (HLA). How are new desensitization protocols opening the door to transplantation for these patients who were previously ineligible? Host Dr. Aaron Carroll talks to Dr. William Goggins, kidney transplant surgical director at Indiana University Health.
Densensitization Therapy for Kidney Transplant Patients
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Some patients needing kidney transplants have to wait much longer than others because of their sensitization to human leukocyte antigen (HLA). How are new desensitization protocols opening the door to transplantation for these patients who were previously ineligible? Host Dr. Aaron Carroll talks to Dr. William Goggins, kidney transplant surgical director at Indiana University Health.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?